~~<i id='CBE3F2A052'><strike id='CBE3F2A052'><tt id='CBE3F2A052'><pre id='CBE3F2A052'></pre></tt></strike></i>~~

Home» knowledge» knowledge

knowledge

author：explore 2025-09-30 02:33:56 Page View：8

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Snowpack in the West is melting rapidly. Where will all that extra water go?
Next article： Supreme Court strikes down use of affirmative action

explore

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Many immigrants are left out of maternal health programs

AdobeIntheU.S.,about16% ofBlackbirthingpeopleareimmigrants.Butevenasthefederalgovernmentandstatestak